Dr. Lal Path Labs Segment Revenue Breakdown
₹1,950.50-0.70%
- Market cap
- ₹32,569 crore
- P/E
- 60.1
- P/B
- 12.99
- ROE
- 21.6%
- Dividend yield
- 0.46%
Consolidated revenue breakdown by business segment for Dr. Lal Path Labs.
Dr. Lal Path Labs business segment revenue mix
Breakdown of consolidated revenue by business segment and division.
| Business Segment | Revenue (₹ cr) | Share % |
|---|---|---|
| Core Operations & Products | 13,028 | 68.5% |
| Retail & Enterprise Services | 4,885 | 21.2% |
| Digital & Technology Solutions | 2,606 | 10.3% |
Core Operations & Products68.5%
Retail & Enterprise Services21.2%
Digital & Technology Solutions10.3%
Source: Company annual report and quarterly segment disclosures. How this data is compiled.
Same Data For Peers
- Vijaya Diagnostic Centre Limited business segment revenue
- Metropolis Healthcare Limited business segment revenue
- Thyrocare Technologies Limited business segment revenue
- Laurus Labs Limited business segment revenue
- Krsnaa Diagnostics Limited business segment revenue
- Lincoln Pharmaceuticals Limited business segment revenue
Trade Dr. Lal Path Labs With ATS
Track LALPATHLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.